Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa

被引：24

作者：

Wendt, S ^{[1
]}

Whybra, C ^{[1
]}

Kampmann, C ^{[1
]}

Teichmann, E ^{[1
]}

Beck, M ^{[1
]}

机构：

[1] Childrens Univ Hosp Mainz, D-55101 Mainz, Germany

来源：

JOURNAL OF INHERITED METABOLIC DISEASE | 2005年 / 28卷 / 05期

关键词：

D O I：

10.1007/s10545-005-0018-9

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Fabry disease is an inherited lysosomal storage disease caused by deficiency of alpha-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy.

引用

页码：787 / 788

页数：2

共 3 条

[1]

Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study [J].